CompletedNCT03674138
Genetic Testing to Guide Antidepressant Choices in Cancer Care
About this title
Read the official source — NCT03674138Study assessmentsAges 18+United StatesDepression
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- TampaSee all locations and recruitment
Study information
Study start dateStarted: September 12, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 99
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Sponsor type
- Research institute
- Study type
- Diagnostic Test
- Intervention type
- Diagnostic test, Other
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03674138
- Official title
Show the full official title
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tampa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is H. Lee Moffitt Cancer Center and Research Institute, a research institute.
Who was this study for?
Listed age limits: from 18 years.
